GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
Beyond the Plaque Paradigm: How Blood Tests, Immune Therapies, and Smart Sensing Are Transforming Global Alzheimer’s Care in 2026
Explore late-October 2026 Alzheimer's research breakthroughs. Discover how high-accuracy blood tests, microglial sleep discoveries, and passive home-sensing healthtech are revolutionizing dementia care and hospice support worldwide.
The Potential of Obicetrapib: Bridging the Gap Between Cardiovascular Health and Alzheimer's Disease
The intricate relationship between cardiovascular health and cognitive function has become increasingly apparent in recent years. Emerging research suggests that what impacts the heart and vascular system may also significantly influence brain health, and vice versa. Among the burgeoning areas of investigation is the potential repurposing of cardiovascular drugs for neurological conditions, specifically Alzheimer's disease. Obicetrapib
Integrated Primary Care: A Path to Better Mental Health
Integrating behavioral health into regular doctor's visits is a game-changer for how we think about and receive mental healthcare. Imagine going to your family doctor for a sore throat, and during that same visit, you can also talk to someone about feeling stressed or anxious. This idea, called Integrated Primary Care (IPC), aims to bring together physical and mental health services under one roof.
Stay Steady, Stay Safe: The Ultimate Guide to Preventing Falls and Fractures as You Age
For many older adults, a simple everyday mishap—like slipping on a wet floor or tripping over a rug—can instantly become a life-altering event. Falls are not just common; they are a significant threat to long-term health, mobility, and independence. Every year, thousands of older adults experience broken bones due to falls.
The Role of AI in Therapeutic Drug Research and Development: Benefits and Challenges
Artificial intelligence (AI) has emerged as a transformative technology across various sectors, and its potential impact on therapeutic drug research and development is significant. By leveraging AI algorithms and machine learning, researchers can potentially accelerate the drug discovery process, identify promising drug candidates, and optimize treatment strategies. However, the integration of AI
The Regulatory Shift: Why Diversity Is Now a Technical Requirement
Discover how Glassbury AI’s agentic NLP platform, SYCQ 1.0, solves the FDA Diversity Action Plan (DAP) mandate and accelerates Phase III Alzheimer’s clinical trial matching.